Literature DB >> 19715661

Lentiviral tracking of vascular differentiation in bone marrow progenitor cells.

Jeffrey Schmeckpeper1, Yasuhiro Ikeda, Arun H S Kumar, Pat Metharom, Stephen J Russell, Noel M Caplice.   

Abstract

Lentiviral vectors encoding for identifiable marker genes controlled by lineage-specific promoters can be used to track differentiation of bone marrow progenitors into endothelial cells and/or smooth muscle cells. Human VE-Cadherin and Smoothelin-B promoters were cloned into a self-inactivating lentiviral vector (HR-VECad and HR-SMTHB) and used to drive expression of green fluorescent protein (eGFP). These constructs demonstrated specific promoter activity in mature endothelial and smooth muscle cells respectively in vitro. Lin(-) bone marrow progenitor cells (Lin(-) BMCs) in culture were used to test vector ability to track vascular differentiation. HR-VECad transduced Lin(-) BMCs were plated on collagen-coated slides and grown in endothelial media, while HR-SMTHB transduced Lin(-) BMCs were cultured on fibronectin-coated slides and grown in smooth muscle media. For in vivo differentiation assessment, lentiviral transduced Lin(-) BMCs resuspended in Matrigel were injected subcutaneously into C57BL/6J mice. Explants were evaluated for eGFP expression. Lin(-) BMCs grown in endothelial differentiation media produced groups of polygonal endothelial-like cells by days 16-21. When transduced with HR-VECad vector, these expressed eGFP in distinct cells within the colony by days 18-21, and coexpressed VE-Cadherin and eNOS. Lin(-) BMCs grown in smooth muscle differentiation media produced spindle-shaped cells between days 10-14 in culture. When transduced with the HR-SMTHB vector, these cells showed eGFP expression at approximately 12 days, which increased over time and coexpressed alphaSMA, calponin and myosin heavy chain. Within Matrigel plugs containing HR-VECad transduced cells, eGFP(+) constituted 0.4+/-0.2% of total cells. In contrast, within Matrigel plugs containing HR-SMTHB transduced cells, eGFP(+) cells constituted 0.2+/-0.1% of total cells. These data demonstrate the feasibility of selectively marking BMC populations for cell fate determination. 2009 International Society of Differentiation. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715661     DOI: 10.1016/j.diff.2009.01.002

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

1.  Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.

Authors:  Yi Zhang; Ge Jiang; Maor Sauler; Patty J Lee
Journal:  FASEB J       Date:  2013-06-14       Impact factor: 5.191

2.  Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo.

Authors:  Santiago Roura; Juli R Bagó; Carolina Soler-Botija; Josep M Pujal; Carolina Gálvez-Montón; Cristina Prat-Vidal; Aida Llucià-Valldeperas; Jerónimo Blanco; Antoni Bayes-Genis
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  Growth enhancement of porcine epidemic diarrhea virus (PEDV) in Vero E6 cells expressing PEDV nucleocapsid protein.

Authors:  Benjamas Liwnaree; Jaraspim Narkpuk; Suttipun Sungsuwan; Anan Jongkaewwattana; Peera Jaru-Ampornpan
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

Review 4.  Strategies for enrichment and selection of stem cell-derived tissue precursors.

Authors:  Harold S Bernstein; William C Hyun
Journal:  Stem Cell Res Ther       Date:  2012-05-10       Impact factor: 6.832

Review 5.  Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing.

Authors:  Patrick Babczyk; Clelia Conzendorf; Jens Klose; Margit Schulze; Kathrin Harre; Edda Tobiasch
Journal:  J Clin Med       Date:  2014-01-15       Impact factor: 4.241

Review 6.  Bioluminescence imaging: a shining future for cardiac regeneration.

Authors:  Santiago Roura; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  J Cell Mol Med       Date:  2013-02-12       Impact factor: 5.310

7.  In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion.

Authors:  Phonphimon Wongthida; Juggragarn Jengarn; Jaraspim Narkpuk; Pongpisid Koonyosying; Kanjana Srisutthisamphan; Asawin Wanitchang; Pornsawan Leaungwutiwong; Samaporn Teeravechyan; Anan Jongkaewwattana
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.